Joachim Listing Selected Research

Joachim Listing Research Topics

Disease

26	Ankylosing Spondylitis 01/2018 - 07/2003
21	Rheumatoid Arthritis 01/2020 - 07/2003
12	Inflammation (Inflammations) 01/2020 - 01/2008
9	Axial Spondyloarthritis 01/2019 - 01/2008
6	Sacroiliitis 01/2019 - 07/2008
6	Back Pain (Backache) 01/2018 - 02/2006
6	Necrosis 10/2017 - 07/2003
6	Arthritis (Polyarthritis) 01/2017 - 03/2002
5	Infections 01/2016 - 11/2005
5	Non-Radiographic Axial Spondyloarthritis 10/2014 - 01/2008
4	Osteitis 01/2019 - 01/2008
4	Rheumatic Diseases (Rheumatism) 01/2016 - 08/2010
3	Spondylarthritis (Spinal Arthritis) 01/2014 - 07/2008
3	Bacterial Infections (Bacterial Infection) 02/2009 - 12/2006
2	Adult-Onset Still's Disease 09/2021 - 01/2020
2	Osteoarthritis 01/2021 - 10/2014
2	Obesity 01/2020 - 01/2020
2	Ankylosis 02/2016 - 07/2003
2	Pain (Aches) 02/2006 - 03/2004
1	Lymphoma (Lymphomas) 12/2017
1	Melanoma (Melanoma, Malignant) 02/2017
1	Myocardial Infarction 01/2016
1	Osteoporosis 01/2016
1	Diabetes Mellitus 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2011
1	Neoplasms (Cancer) 01/2010
1	Uveitis 03/2009
1	Virus Diseases (Viral Diseases) 02/2009
1	Herpes Zoster 02/2009
1	Heart Failure 03/2008
1	Opportunistic Infections (Opportunistic Infection) 12/2006
1	Low Back Pain (Lumbago) 02/2006
1	Spondylarthropathies 03/2004
1	Psoriatic Arthritis 07/2003
1	Spinal Diseases (Disease, Spinal) 07/2003

Drug/Important Bio-Agent (IBA)

14	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 03/2004
12	Tumor Necrosis Factor InhibitorsIBA 01/2020 - 07/2003
12	Etanercept (Enbrel)FDA Link 01/2019 - 07/2003
10	Antirheumatic Agents (DMARD)IBA 04/2018 - 03/2002
9	C-Reactive ProteinIBA 01/2019 - 03/2009
9	Infliximab (Remicade)FDA Link 01/2016 - 07/2003
9	Adalimumab (Humira)FDA Link 01/2014 - 07/2003
8	Biological ProductsIBA 01/2020 - 11/2005
7	Pharmaceutical PreparationsIBA 01/2020 - 09/2010
7	Methotrexate (Mexate)FDA LinkGeneric 10/2016 - 03/2002
6	HLA-B27 Antigen (HLA B27 Antigen)IBA 06/2013 - 07/2008
4	CytokinesIBA 09/2021 - 11/2011
4	Rituximab (Mabthera)FDA Link 01/2020 - 02/2013
4	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2019 - 07/2003
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2017 - 10/2012
4	GlucocorticoidsIBA 01/2016 - 03/2008
3	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 01/2018 - 02/2006
3	AntibodiesIBA 02/2009 - 12/2006
2	canakinumab FDA Link 09/2021 - 01/2020
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021 - 10/2014
2	tocilizumab (atlizumab)FDA Link 01/2020 - 04/2018
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 05/2012 - 03/2004
1	Abatacept (Orencia)FDA Link 01/2020
1	InterleukinsIBA 01/2020
1	amsonic acid (DAS)IBA 01/2020
1	factor AIBA 10/2017
1	Celecoxib (Celebrex)FDA Link 10/2017
1	AdipokinesIBA 01/2017
1	AdiponectinIBA 01/2017
1	LeptinIBA 01/2017
1	HLA-DRB4 Chains (HLA DRB4)IBA 10/2016
1	Diclofenac (SR 38)FDA LinkGeneric 08/2016
1	Naproxen (Naprosyn)FDA LinkGeneric 01/2016
1	Leflunomide (Arava)FDA LinkGeneric 11/2014
1	N 30IBA 10/2014
1	Ustekinumab (CNTO 1275)FDA Link 05/2014
1	brassIBA 08/2010
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2010
1	Proteins (Proteins, Gene)FDA Link 02/2009
1	Monoclonal AntibodiesIBA 02/2009
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2008
1	Biomarkers (Surrogate Marker)IBA 01/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2008
1	Complement System Proteins (Complement)IBA 11/2006

Therapy/Procedure

16	Therapeutics 01/2020 - 07/2003
9	Biological Therapy 01/2020 - 01/2006
1	Retreatment 03/2007